ArticleCureus2025
Comparison of Short-Term Outcomes: Minimally Invasive Thoracotomy Versus Median Sternotomy for Atrial Septal Defect Closure.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Evaluating the efficacy of right vertical infra-axillary thoracotomy vs. standard median sternotomy for atrial septal defect repairs: A single center analysis from Pakistan.Pakistan journal of medical sciences · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThis study aimed to compare the early outcomes of atrial septal defect (ASD) surgeries performed using minimally invasive (MI) thoracotomy versus conventional median sternotomy (MS). MATERIALS AND
methodsFifty patients with ASD were included in this study conducted at Bangabandhu Sheikh Mujib Medical University, Dhaka. Fifteen patients underwent MI thoracotomy (Group A), while 35 underwent conventional MS (Group B). Eligible patients were over 16 years old with a single ASD, while those requiring additional interventions were excluded. Demographic data, surgical details, and outcomes were analyzed using SPSS Statistics version 26.0 (IBM Corp. Released 2019. IBM SPSS Statistics for Windows, Version 26.0. Armonk, NY: IBM Corp.). Pain levels, complications, and other variables were compared using appropriate statistical tests, with a p-value <0.05 considered statistically significant. The study adhered to ethical guidelines and received institutional approval.
resultsEarly outcomes of ASD surgeries were analyzed between the two groups. Group A had a younger mean age (31.77 ± 2.64 years) compared to Group B (36.33 ± 12.61 years), although the difference was not statistically significant (p = 0.624). Both groups had similar body mass index (BMI), ASD size, and gender distribution. Group A experienced significantly longer operation times and lower intraoperative body temperatures (p < 0.001). Postoperative drainage was higher in Group A (p = 0.048). However, Group B required more inotropic support (25.71% vs. 13.33%, p = 0.011) and had more significant pain management needs during the recovery period. No significant differences were observed in other outcomes or complications between the groups.
conclusionsMI thoracotomy for ASD closure offers several advantages over conventional MS, including reduced pain, faster recovery, and shorter hospital stays. Patients in the MI thoracotomy group experienced fewer complications, including atrial fibrillation, arrhythmias, and atelectasis, with no cases of reoperation for bleeding, neurological complications, wound infections, conversions to sternotomy, or mortality. They also required less analgesia and benefited from superior cosmetic outcomes, making this approach a more favorable option, particularly for younger patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.